Health tech companies increasingly promote personalized health solutions, using algorithms and wearable devices to tailor recommendations. However, a 2025 study in the Journal of Medical Internet Research found that most consumer health apps fail to adequately account for chronic conditions like diabetes or hypertension, which affect 60% of U.S. adults according to the CDC.
Experts note that algorithms often rely on general population data, not individual medical histories. Dr. Sarah Johnson, a digital health researcher at Stanford, told Reuters in March 2026: 'These tools can mislead patients with chronic diseases if they don't integrate clinical data.'
For example, a 2024 analysis by the American Heart Association showed that fitness trackers underestimate heart rate variability in people with arrhythmias. Without proper validation, personalized health features may offer false reassurance or harmful advice.
Regulators are taking notice. The FDA has issued guidance in 2025 requiring more rigorous testing for AI-driven health apps. Companies like Apple and Fitbit have begun partnering with medical institutions to improve accuracy for chronic conditions, but adoption remains slow.
As the market grows—projected to reach $1.5 trillion by 2030 per Grand View Research—the gap between promise and reality underscores the need for inclusive design that prioritizes chronic disease management.
